GL

Gopal Laxminarayan Zanvar

Active Director Director DIN 02526979
DIN 02526979 First appointment Jan 2003 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Jan 2003
Shareholding value •••• Premium profile

About Gopal Laxminarayan Zanvar

Data last updated:

Gopal Laxminarayan Zanvar is a Director at Bayberry Pharmaceuticals Private Limited (since 2009), Director at Garron Labs Private Limited (since 2017) and Designated Partner at Bayberry Naturus Llp (since 2023). The companies operate in Pharma, Consumer Goods and Food and Beverages. The 2 current companies with reported revenue have a combined latest revenue of ₹19.67 Cr; the largest is Bayberry Pharmaceuticals Private Limited at ₹18.82 Cr (FY 2025). Earlier, Gopal Laxminarayan Zanvar was a Director at Cian Healthcare Limited (2003–2009).

DIN 02526979
Primary Designation Director
Industry Pharma
First Appointment 07 Jan 2003
Oldest Company Age 17 yrs
Largest company Bayberry Pharmaceuticals Private Limited · ₹18.82 Cr (FY 2025)
Combined revenue ₹19.67 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 May 20092009₹18.82 Cr (FY 2025)Active
Garron Labs Private Limited U51909PN2013PTC147604
Director15 Mar 20172013₹85.6 Lakh (FY 2020)Active
Designated Partner18 Aug 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cian Healthcare Limited L24233PN2003PLC017563
Director07 Jan 20032003₹62.14 Cr (FY 2024)Under Cirp

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Gopal Laxminarayan Zanvar

Directorship timeline

Open interactive timeline →
Bayberry Pharmaceuticals Private Limited
Garron Labs Private Limited
Bayberry Naturus Llp
Cian Healthcare Limited
Premium access

Shareholding and investment profile for Gopal Laxminarayan Zanvar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gopal Laxminarayan Zanvar

Gopal Laxminarayan Zanvar currently holds 3 directorships: Bayberry Pharmaceuticals Private Limited (Director, since 07 May 2009, revenue ₹18.82 Cr (FY 2025)); Garron Labs Private Limited (Director, since 15 Mar 2017, revenue ₹85.6 Lakh (FY 2020)); Bayberry Naturus Llp (Designated Partner, since 18 Aug 2023).

Gopal Laxminarayan Zanvar was first appointed on 07 Jan 2003 as Director at Cian Healthcare Limited. The most recent appointment on record is 18 Aug 2023 at Bayberry Naturus Llp.

The 2 current companies of Gopal Laxminarayan Zanvar that report revenue have a combined latest revenue of ₹19.67 Cr: Bayberry Pharmaceuticals Private Limited ₹18.82 Cr (FY 2025); Garron Labs Private Limited ₹85.6 Lakh (FY 2020).

Gopal Laxminarayan Zanvar held 1 earlier board appointment: Cian Healthcare Limited (Director, 07 Jan 2003 to 09 Nov 2009).

The current boards of Gopal Laxminarayan Zanvar's companies include Sandeep Laxminaray Zanwar (Bayberry Pharmaceuticals Private Limited), Ashish Mohanlal Gundecha (Garron Labs Private Limited), Rahul Manikchand Bhandari (Garron Labs Private Limited), Abhishek Radhesham Bhandari (Bayberry Naturus Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available